Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Show more...
CEO
Blaise Coleman
Zaměstnanci
2931
Země
Irsko
ISIN
IE00BJ3V9050
WKN
000A1XE6M
Zalistování
0 Comments
Poděl se o svůj názor
FAQ
Jaká je dnes cena akcie společnosti Endo International?▼
Aktuální cena ENDPQ je $0,00 USD — za posledních 24 hodin vzrostla o +0%. Vývoj ceny akcie společnosti Endo International můžete podrobněji sledovat v grafu.
Jaký ticker má akcie společnosti Endo International?▼
Ticker akcie se může lišit podle burzy. Například na burze se akcie společnosti Endo International obchodují pod tickerem ENDPQ.
Jaké byly tržby společnosti Endo International za minulý rok?▼
Tržby společnosti Endo International za poslední rok činí 2,01B USD.
Jaký je čistý zisk společnosti Endo International za minulý rok?▼
Čistý zisk ENDPQ za poslední rok činí -2,45B USD.
Kolik má Endo International zaměstnanců?▼
Ke dni června 11, 2026 má společnost 2 931 zaměstnanců.
Do jakého sektoru patří Endo International?▼
Endo International působí v sektoru Technology.
Kdy společnost Endo International provedla split akcií?▼
Společnost Endo International v poslední době neprovedla žádný split akcií.
Kde má Endo International sídlo?▼
Endo International má sídlo ve městě Dublin, Irsko.